Intensity-Modulated Radiation Therapy for Anal Cancer

被引：0
|
作者：
Czito, Brian G. [1 ]
Pepek, Joseph M.
Meyer, Jeffrey J. [2 ]
Yoo, Sua
Willett, Christopher G.
机构：
[1] Duke Univ, Med Ctr, Sch Med, Dept Radiat Oncol, Durham, NC 27710 USA
[2] Univ Texas SW, Dept Radiat Oncol, Dallas, TX USA
来源：
ONCOLOGY-NEW YORK | 2009年 / 23卷 / 12期
关键词：
ACUTE HEMATOLOGIC TOXICITY; WHOLE PELVIC RADIOTHERAPY; SQUAMOUS-CELL CARCINOMA; CONCURRENT CHEMOTHERAPY; CONFORMAL RADIOTHERAPY; FDG-PET/CT; MANAGEMENT; MITOMYCIN; IMRT; FLUOROURACIL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The contemporary treatment of anal cancer is combined-modality therapy with radiation therapy, fluorouracil, and mitomycin. This therapy results in long-term disease-free survival and sphincter preservation in the majority of patients. Tempering these positive results is the high rate of treatment-related morbidity associated with chemoradiation therapy for anal cancer. The use of intensity-modulated radiation therapy (IMRT) has the potential to reduce acute and chronic treatment-related toxicity, minimize treatment breaks, and potentially improve disease-related outcomes by permitting radiation dose escalation in selected cases.
引用
收藏
页码：1082 / 1089
页数：8
相关论文
共 50 条
  • [1] Intensity-modulated radiation therapy for the treatment of anal cancer
    Lin, Alexander
    Ben-Josef, Edgar
    [J]. CLINICAL COLORECTAL CANCER, 2007, 6 (10) : 716 - 719
  • [2] Hematologic Toxicity Comparison of Intensity-Modulated Proton Therapy and Intensity-Modulated Radiation Therapy in Anal Cancer Patients
    Nelson, B.
    Tadesse, D.
    Wang, K.
    Meier, T.
    Mascia, A. E.
    Kharofa, J. R., Jr.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E64 - E65
  • [3] Intensity-modulated radiation therapy for anal carcinoma
    Peiffert, D.
    Moreau-Claeys, M. -V.
    Tournier-Rangeard, L.
    Huger, S.
    Marchesi, V.
    [J]. CANCER RADIOTHERAPIE, 2011, 15 (6-7): : 549 - 554
  • [4] Quality of life after intensity-modulated radiation therapy for anal cancer
    Tang, Yu
    Crane, Christopher H.
    Eng, Cathy
    Minsky, Bruce D.
    Delclos, Marc E.
    Krishnan, Sunil
    Malatek, Daniel
    Gould, Morris S.
    Das, Prajnan
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2015, 4 (03) : 291 - 298
  • [5] Intensity-Modulated Radiation Therapy for Anal Cancer: Toxicity versus Outcomes
    Zagar, Timothy M.
    Willett, Christopher G.
    Czito, Brian G.
    [J]. ONCOLOGY-NEW YORK, 2010, 24 (09): : 815 - 828
  • [6] Toxicity and survival of anal cancer patients treated with intensity-modulated radiation therapy
    Ghareeb, A.
    Paramasevon, K.
    Mokool, P.
    van der Voet, H.
    Jha, M.
    [J]. ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2019, 101 (03) : 168 - 175
  • [7] Toxicity and survival of anal cancer patients treated with Intensity-Modulated Radiation Therapy
    Ghareeb, A.
    Rajoo, K.
    Aitken, D.
    Reddy, A.
    Garg, D.
    van der Voet, H.
    Jha, M.
    [J]. BRITISH JOURNAL OF SURGERY, 2018, 105 : 27 - 27
  • [8] Intensity-Modulated Radiation Therapy for Anal Cancer: An Obvious yet Complicated Transition
    Herman, Joseph M.
    Thomas, Charles R., Jr.
    [J]. ONCOLOGY-NEW YORK, 2010, 24 (09): : 828 - 831
  • [9] Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Anal Cancer Outcomes and Toxicity
    Mitchell, Melissa P.
    Abboud, Mirna
    Eng, Cathy
    Beddar, A. Sam
    Krishnan, Sunil
    Delclos, Marc E.
    Crane, Christopher H.
    Das, Prajnan
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (05): : 461 - 466
  • [10] Intensity-Modulated Radiation Therapy for Prostate Cancer
    Sartor, Oliver
    Silberstein, Jonathan L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (07): : 679 - 679
12345